[Causative immunopathologic mechanisms in pediatric urticaria following primary injection with anti-hepatitis B vaccine].
Barbaud
A
A
Reichert-Pénétrat
S
S
Béné
M C
MC
Kolopp-Sarda
M N
MN
Faure
G
G
Kohler
C
C
Schmutz
J L
JL
D002648:Child; D016207:Cytokines / Q000097:blood; D003875:Drug Eruptions / Q000276:immunology* / Q000473:pathology; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007428:Intradermal Tests; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008297:Male; D010328:Patch Tests; D012867:Skin / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014581:Urticaria / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology
D016207:Cytokines; C075654:Engerix-B; D017325:Hepatitis B Vaccines; C075657:Hevac B; D014614:Vaccines, Synthetic